Hypoglycemia and the origin of hypoxia-induced reduction in human fetal growth

Stacy Zamudio, Tatiana Torricos, Ewa Fik, Maria Oyala, Lourdes Echalar, Janet Pullockaran, Emily Tutino, Brittney Martin, Sonia Belliappa, Elfride Balanza, Nicholas P Illsley, Stacy Zamudio, Tatiana Torricos, Ewa Fik, Maria Oyala, Lourdes Echalar, Janet Pullockaran, Emily Tutino, Brittney Martin, Sonia Belliappa, Elfride Balanza, Nicholas P Illsley

Abstract

Background: The most well known reproductive consequence of residence at high altitude (HA >2700 m) is reduction in fetal growth. Reduced fetoplacental oxygenation is an underlying cause of pregnancy pathologies, including intrauterine growth restriction and preeclampsia, which are more common at HA. Therefore, altitude is a natural experimental model to study the etiology of pregnancy pathophysiologies. We have shown that the proximate cause of decreased fetal growth is not reduced oxygen availability, delivery, or consumption. We therefore asked whether glucose, the primary substrate for fetal growth, might be decreased and/or whether altered fetoplacental glucose metabolism might account for reduced fetal growth at HA.

Methods: Doppler and ultrasound were used to measure maternal uterine and fetal umbilical blood flows in 69 and 58 residents of 400 vs 3600 m. Arterial and venous blood samples from mother and fetus were collected at elective cesarean delivery and analyzed for glucose, lactate and insulin. Maternal delivery and fetal uptakes for oxygen and glucose were calculated.

Principal findings: The maternal arterial - venous glucose concentration difference was greater at HA. However, umbilical venous and arterial glucose concentrations were markedly decreased, resulting in lower glucose delivery at 3600 m. Fetal glucose consumption was reduced by >28%, but strongly correlated with glucose delivery, highlighting the relevance of glucose concentration to fetal uptake. At altitude, fetal lactate levels were increased, insulin concentrations decreased, and the expression of GLUT1 glucose transporter protein in the placental basal membrane was reduced.

Conclusion/significance: Our results support that preferential anaerobic consumption of glucose by the placenta at high altitude spares oxygen for fetal use, but limits glucose availability for fetal growth. Thus reduced fetal growth at high altitude is associated with fetal hypoglycemia, hypoinsulinemia and a trend towards lactacidemia. Our data support that placentally-mediated reduction in glucose transport is an initiating factor for reduced fetal growth under conditions of chronic hypoxemia.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Maternal glucose concentrations and uterine…
Figure 1. Maternal glucose concentrations and uterine glucose delivery.
(A) Maternal arterial and venous plasma glucose concentrations in normal, term pregnancies at low vs. high altitude. Arterial glucose concentrations were similar at low (4.3±0.1 mM) and high altitude (4.5±0.1 mM, p = 0.06), but venous concentrations were reduced at high altitude (3.5±0.1 at 400 m and 3.2±0.1 at 3600 m, p−1.kg−1 uterine contents) and 3600 m (0.63±0.04 mmol.min−1.kg−1 uterine contents, p = 0.06).
Figure 2. Fetal glucose concentrations and fetal…
Figure 2. Fetal glucose concentrations and fetal glucose consumption.
(A) Umbilical venous and arterial plasma glucose concentrations in normal, term pregnancies at 400 and 3600 m. Glucose concentrations were greater in the umbilical vein at 400 m (3.5±0.1 mM) than at 3600 m (2.9±0.1 mM, p

Figure 3. Indicators of fetal glucose metabolism.

Figure 3. Indicators of fetal glucose metabolism.

(A) The fetal glucose/oxygen quotient (6 x fetal…

Figure 3. Indicators of fetal glucose metabolism.
(A) The fetal glucose/oxygen quotient (6 x fetal glucose consumption/fetal oxygen consumption) was greater at 400 m (1.64±0.13) than at 3600 m (1.18±0.13 p2 = 0.18, p<0.001 at 400 m; y = 0.23+0.35x, r2 = 0.43, p<0.0001 at 3600 m).

Figure 4. Fetal lactate and insulin response…

Figure 4. Fetal lactate and insulin response to altered glucose delivery and consumption.

(A) Umbilical…

Figure 4. Fetal lactate and insulin response to altered glucose delivery and consumption.
(A) Umbilical venous plasma lactate concentrations in normal, term pregnancies at 400 vs 3600 m did not differ (3.36±0.09 mM at 400 m and 3.67±0.13 mM at 3600 m, p = 0.06), whilst arterial concentrations were lower at 400 m (3.22±0.11 mM) than at 3600 m (3.80±0.17, p−1 [54.1–170.1]; high altitude, median  = 53.5 pmol.ml−1 [38.2–79.2]). (C) Fetal glucose and insulin concentrations were positively correlated at both altitudes (400 m y  = −65.2+52.4x r2 = 0.34, p<0.0001; 3600 m y  = −49.4+40.5x, r2 = 0.33, p<0.0001) but neither the slopes (p = 0.42) nor intercept (p = 0.11) differed.
Figure 3. Indicators of fetal glucose metabolism.
Figure 3. Indicators of fetal glucose metabolism.
(A) The fetal glucose/oxygen quotient (6 x fetal glucose consumption/fetal oxygen consumption) was greater at 400 m (1.64±0.13) than at 3600 m (1.18±0.13 p2 = 0.18, p<0.001 at 400 m; y = 0.23+0.35x, r2 = 0.43, p<0.0001 at 3600 m).
Figure 4. Fetal lactate and insulin response…
Figure 4. Fetal lactate and insulin response to altered glucose delivery and consumption.
(A) Umbilical venous plasma lactate concentrations in normal, term pregnancies at 400 vs 3600 m did not differ (3.36±0.09 mM at 400 m and 3.67±0.13 mM at 3600 m, p = 0.06), whilst arterial concentrations were lower at 400 m (3.22±0.11 mM) than at 3600 m (3.80±0.17, p−1 [54.1–170.1]; high altitude, median  = 53.5 pmol.ml−1 [38.2–79.2]). (C) Fetal glucose and insulin concentrations were positively correlated at both altitudes (400 m y  = −65.2+52.4x r2 = 0.34, p<0.0001; 3600 m y  = −49.4+40.5x, r2 = 0.33, p<0.0001) but neither the slopes (p = 0.42) nor intercept (p = 0.11) differed.

References

    1. Hack M, Weissman B, Breslau N, Klein N, Borawski-Clark E, et al. Health of very low birth weight children during their first eight years. J Pediatr. 1993;122:887–892.
    1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, et al. Births: final data for 2005. National Vital Statistics Reports. 2007;56:1–103.
    1. Cnattingius S, Haglund B, Kramer MS. Differences in late fetal death rates in association with determinants of small for gestational age fetuses: population based cohort study. Br Med J. 1998;316:1483–1487.
    1. Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol. 2001;184:946–953.
    1. Mongelli M, Gardosi J. Fetal growth. Curr Opin Obstet Gynecol. 2000;12:111–115.
    1. Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev. 2009;6(Suppl 3):332–336.
    1. Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta. 1997;18:613–621; discussion 623-616.
    1. Zamudio S, Postigo L, Illsley NP, Rodriguez C, Heredia G, et al. Maternal oxygen delivery is not related to altitude- and ancestry-associated differences in human fetal growth. J Physiol. 2007;582:883–895.
    1. Giussani DA, Salinas CE, Villena M, Blanco CE. The role of oxygen in prenatal growth: studies in the chick embryo. J Physiol. 2007;585:911–917.
    1. Kitanaka T, Alonso JG, Gilbert RD, Siu BL, Clemons GK, et al. Fetal responses to long-term hypoxemia in sheep. Am J Physiol. 1989;256:R1348–1354.
    1. Kitanaka T, Gilbert RD, Longo LD. Maternal responses to long-term hypoxemia in sheep. Am J Physiol. 1989;256:R1340–1347.
    1. Moore LG, Niermeyer S, Zamudio S. Human adaptation to high altitude: regional and life-cycle perspectives. Am J Phys Anthropol Suppl. 1998:25–64.
    1. Jensen GM, Moore LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Publ Health. 1997;87:1003–1007.
    1. Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab. 2005;90:4299–4308.
    1. Zamudio S, Baumann MU, Illsley NP. Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters. Placenta. 2006;27:49–55.
    1. Zamudio S, Wu Y, Ietta F, Rolfo A, Cross A, et al. Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo. Am J Pathol. 2007;170:2171–2179.
    1. Postigo L, Heredia G, Illsley NP, Torricos T, Dolan C, et al. Where the O2 goes to: preservation of human fetal oxygen delivery and consumption at high altitude. J Physiol. 2009;587:693–708.
    1. Moore LG, Shriver M, Bemis L, Hickler B, Wilson M, et al. Maternal adaptation to high-altitude pregnancy: an experiment of nature–a review. Placenta. 2004;25(Suppl A):S60–71.
    1. Wilson MJ, Lopez M, Vargas M, Julian C, Tellez W, et al. Greater uterine artery blood flow during pregnancy in multigenerational (Andean) than shorter-term (European) high-altitude residents. Am J Physiol. 2007;293:R1313–1324.
    1. Carter AM. Factors affecting gas transfer across the placenta and the oxygen supply to the fetus. [Review] [132 refs]. J Dev Physiol. 1989;12:305–322.
    1. Lackman F, Capewell V, Gagnon R, Richardson B. Fetal umbilical cord oxygen values and birth to placental weight ratio in relation to size at birth. Am J Obstet Gynecol. 2001;185:674–682.
    1. Palmer SK, Zamudio S, Coffin C, Parker S, Stamm E, et al. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol. 1992;80:1000–1006.
    1. Sonnenberg GE, Keller U. Sampling of arterialized heated-hand venous blood as a noninvasive technique for the study of ketone body kinetics in man. Metabolism. 1982;31:1–5.
    1. McLoughlin P, Popham P, Linton RA, Bruce RC, Band DM. Use of arterialized venous blood sampling during incremental exercise tests. J Appl Physiol. 1992;73:937–940.
    1. Ronzoni S, Marconi AM, Paolini CL, Teng C, Pardi G, et al. The effect of a maternal infusion of amino acids on umbilical uptake in pregnancies complicated by intrauterine growth restriction. Am J Obstet Gynecol. 2002;187:741–746.
    1. Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab. 1999;84:695–701.
    1. Sutton MS, Theard MA, Bhatia SJ, Plappert T, Saltzman DH, et al. Changes in placental blood flow in the normal human fetus with gestational age. Pediatr Res. 1990;28:383–387.
    1. Barbera A, Galan HL, Ferrazzi E, Rigano S, Jozwik M, et al. Relationship of umbilical vein blood flow to growth parameters in the human fetus. Am J Obstet Gynecol. 1999;181:174–179.
    1. Galan HL, Jozwik M, Rigano S, Regnault TR, Hobbins JC, et al. Umbilical vein blood flow determination in the ovine fetus: comparison of Doppler ultrasonographic and steady-state diffusion techniques. Am J Obstet Gynecol. 1999;181:1149–1153.
    1. Kunst A, Draeger B, Ziegenhorn J. Glucose: UV-methods with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer H, editor. Method in Enzymatic Analysis. Deerfield Beach, FL: Verlag Chemie; 1984. pp. 163–172.
    1. Engel PC, Jones JB. Causes and elimination of erratic blanks in enzymatic metabolite assays involving the use of NAD+ in alkaline hydrazine buffers: improved conditions for the assay of L-glutamate, L-lactate, and other metabolites. Anal Biochem. 1978;88:475–484.
    1. Gilfillan CA, Tserng KY, Kalhan SC. Alanine production by the human fetus at term gestation. Biol Neonate. 1985;47:141–147.
    1. Marconi AM, Cetin I, Davoli E, Baggiani AM, Fanelli R, et al. An evaluation of fetal glucogenesis in intrauterine growth-retarded pregnancies. Metabolism. 1993;42:860–864.
    1. Acharya G, Wilsgaard T, Rosvold Berntsen GK, Maltau JM, Kiserud T. Reference ranges for umbilical vein blood flow in the second half of pregnancy based on longitudinal data. Prenat Diagn. 2005;25:99–111.
    1. Bernstein IM, Ziegler WF, Leavitt T, Badger GJ. Uterine artery hemodynamic adaptations through the menstrual cycle into early pregnancy. Obstet Gynecol. 2002;99:620–624.
    1. Konje JC, Howarth ES, Kaufmann P, Taylor DJ. Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction. Br J Obstet Gynaecol. 2003;110:301–305.
    1. Zamudio S. High-altitude hypoxia and preeclampsia. Front Biosci. 2007;12:2967–2977.
    1. Acharya G, Sitras V. Oxygen uptake of the human fetus at term. Acta Obstet Gynecol Scand. 2009;88:104–109.
    1. Krampl E, Kametas NA, Cacho Zegarra AM, Roden M, Nicolaides KH. Maternal plasma glucose at high altitude. Br J Obstet Gynaecol. 2001;108:254–257.
    1. Krampl E, Kametas NA, Nowotny P, Roden M, Nicolaides KH. Glucose metabolism in pregnancy at high altitude. Diabetes Care. 2001;24:817–822.
    1. Bozzetti P, Ferrari M, Marconi A, Ferrazzi E, Pardi G, et al. The relationship of maternal and fetal glucose concentrations in the human from midgestation until term. Metabolism. 1988;37:358–363.
    1. DeSanto JT, Nagomi W, Liechty EA, Lemons JA. Blood ammonia concentration in cord blood during pregnancy. Early Hum Dev. 1993;33:1–8.
    1. Economides DL, Nicolaides KH. Blood glucose and oxygen tension levels in small-for-gestational-age fetuses.[see comment]. Am J Obstet Gynecol. 1989;160:385–389.
    1. Marconi AM, Paolini C, Buscaglia M, Zerbe G, Battaglia FC, et al. The impact of gestational age and fetal growth on the maternal-fetal glucose concentration difference. Obstet Gynecol. 1996;87:937–942.
    1. Nicolini U, Hubinont C, Santolaya J, Fisk NM, Coe AM, et al. Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated by alloimmunization and fetal growth retardation. Am J Obstet Gynecol. 1989;161:924–927.
    1. Hubinont C, Nicolini U, Fisk NM, Tannirandorn Y, Rodeck CH. Endocrine pancreatic function in growth-retarded fetuses. Obstet Gynecol. 1991;77:541–544.
    1. Setia S, Sridhar MG, Bhat V, Chaturvedula L, Vinayagamoorti R, et al. Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants. Pathology. 2006;38:236–238.
    1. Gruppuso PA, Migliori R, Susa JB, Schwartz R. Chronic maternal hyperinsulinemia and hypoglycemia. A model for experimental intrauterine growth retardation. Biol Neonate. 1981;40:113–120.
    1. Lueder FL, Buroker CA, Kim SB, Flozak AS, Ogata ES. Differential effects of short and long durations of insulin-induced maternal hypoglycemia upon fetal rat tissue growth and glucose utilization. Pediatr Res. 1992;32:436–440.
    1. Kamei Y, Tsutsumi O, Yamakawa A, Oka Y, Taketani Y, et al. Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucose transporter GLUT3 expression. Endocrinology. 1999;140:4236–4243.
    1. Carver TD, Quick AA, Teng CC, Pike AW, Fennessey PV, et al. Leucine metabolism in chronically hypoglycemic hypoinsulinemic growth-restricted fetal sheep. Am J Physiol. 1997;272:E107–117.
    1. Rosenn BM, Miodovnik M. Glycemic control in the diabetic pregnancy: is tighter always better? J Matern Fetal Med. 2000;9:29–34.
    1. Khouzami VA, Ginsburg DS, Daikoku NH, Johnson JW. The glucose tolerance test as a means of identifying intrauterine growth retardation. Am J Obstet Gynecol. 1981;139:423–426.
    1. Van Assche FA, De Prins FA. Maternal hypoglycemia and intrauterine growth retardation. Am J Obstet Gynecol. 1983;146:349–350.
    1. Takaya J, Yamato F, Higashino H, Kaneko K. Intracellular magnesium and adipokines in umbilical cord plasma and infant birth size. Pediatr Res. 2007;62:700–703.
    1. Alkalay AL, Sarnat HB, Flores-Sarnat L, Elashoff JD, Farber SJ, et al. Population meta-analysis of low plasma glucose thresholds in full-term normal newborns. Am J Perinatol. 2006;23:115–119.
    1. Vardhana P, Illsley N. Transepithelial glucose transport and metabolism in BeWo choriocarcinoma cells. Placenta. 2002;23:653–660.
    1. Baumann M, Zamudio S, Illsley N. Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1 (HIF-1). Am J Physiol. 2007;293:C477–485.
    1. Esterman A, Greco MA, Mitani Y, Finlay TH, Ismail-Beigi F, et al. The effect of hypoxia on human trophoblast in culture: morphology, glucose transport and metabolism. Placenta. 1997;18:129–136.
    1. Illsley N, Hall S, Stacey T. The modulation of glucose transfer across the human placenta by intervillous flow rates: an invitro perfusion study. Trophoblast Res. 1987;2:535–544.
    1. Hay WW., Jr Recent observations on the regulation of fetal metabolism by glucose. J Physiol. 2006;572:17–24.
    1. Marconi AM, Paolini C, Buscaglia M, Zerbe G, Battaglia FC, et al. The impact of gestational age and fetal growth on the maternal-fetal glucose concentration difference. Obstet Gynecol. 1996;87:937–942.
    1. Marconi AM, Paolini CL, Zerbe G, Battaglia FC. Lactacidemia in intrauterine growth restricted (IUGR) pregnancies: relationship to clinical severity, oxygenation and placental weight. Pediatr Res. 2006;59:570–574.
    1. Brahimi-Horn C, Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Canc. 2006;93:E73–80.
    1. Semenza GL. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J. 2007;405:1–9.
    1. Aragones J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet. 2008;40:170–180.
    1. Mason SD, Rundqvist H, Papandreou I, Duh R, McNulty WJ, et al. HIF-1alpha in endurance training: suppression of oxidative metabolism. Am J Physol. 2007;293:R2059–2069.
    1. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. New Engl J Med. 2008;359:61–73.
    1. Limesand SW, Jensen J, Hutton JC, Hay WW., Jr Diminished beta-cell replication contributes to reduced beta-cell mass in fetal sheep with intrauterine growth restriction. American Journal of Physiology. 2005;288:R1297–1305.
    1. Rozance PJ, Limesand SW, Hay WW., Jr Decreased nutrient-stimulated insulin secretion in chronically hypoglycemic late-gestation fetal sheep is due to an intrinsic islet defect. Am J Physiol. 2006;291:E404–411.
    1. Rozance PJ, Limesand SW, Zerbe GO, Hay WW., Jr Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic beta-cells. Am J Physiol. 2007;292:E1256–1264.

Source: PubMed

3
Suscribir